CompaniesAxerion Therapeutics

Axerion Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

64

By Phase

PHASE1: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05717686Lead Sponsor

A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

PHASE1Completed

64 participants

Started: Feb 28, 2023 · Completed: Jan 7, 2025

Funding History (6)

D/A

Sep 28, 2020

D

Dec 2, 2019

D/A

Jul 9, 2019

D

Apr 9, 2018

D

Dec 29, 2017

D

Apr 14, 2010